T. Kropotina

Ways to improve the diagnosis and treatment of interstitial lung disease associated with systemic sclerosis in the Siberian Federal District (materials of the advisory board of rheumatologists and pulmonologists from December 08, 2019)

L. M. Kudelya, O. Anoshenkova, D. Orlov, 2020 .

OP0232 NETAKIMAB REDUCES THE DISEASE ACTIVITY OF RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS. RESULTS OF ASTERA STUDY

V. Mazurov, I. Gordeev, T. Dubinina, 2019, Oral Presentations.

SYSTEM OF THE HEMOSTASIS IN PATIENTS WITH RHEUMATOID ARTHRITIS COMBINED WITH ISCHEMIC HEART DISEASE DURING THERAPY WITH NONSTEROIDAL ANTI@INFLAMMATORY DRUGS AND ASPIRIN

N. Morova, T. Kropotina, 2012 .

Efficacy and safety of netakimab, anti-IL-17A monoclonal antibody, in patients with ankylosing spondylitis. Results of phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA

V. Mazurov, S. Lapshina, I. Gordeev, 2020, Rheumatology Science and Practice.

Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR

V. Mazurov, A. Lila, M. Korolev, 2023, Rheumatology Science and Practice.

COMPARATIVE EVALUATION OF THE LONG-TERM EFFICACY AND SAFETY OF THE INFLIXIMAB BIOSIMILAR BCD-055 AND REFERENCE INFLIXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS OF THE INTERNATIONAL MULTICENTER RANDOMIZED DOUBLE-BLIND PHASE III CLINICAL STUDY ASART-2

V. Mazurov, A. Lila, I. Gordeev, 2018, Rheumatology Science and Practice.

Long-term efficacy and safety of netakimab in the treatment of ankylosing spondylitis: results of Phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA

S. Lapshina, I. Gordeev, T. Dubinina, 2020, Modern Rheumatology Journal.